Rockwell Medical (RMTI) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Rockwell Medical (RMTI) is Neutral.

The composite score behind that read is -0.18, weighing +0.13 of bullish evidence against -0.34 bearish.

Rockwell Medical last closed at $8.23, -4.86% on the session.

Against the IVW growth benchmark the position is -5.78% over the forecast window.

The read is built from 12 underlying insights — 4 bullish and 8 bearish.

Agreement across those insights is 67%.

16 graded predictions for RMTI so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Rockwell Medical in the 29th percentile on return on equity, where 100 is best.

Rockwell Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $34.86M.

StockMap tracks Rockwell Medical as the 115th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Rockwell Medical ranks 65th of 133 in the group, against a group median of -0.21.